Lindsay Davies, an affiliated researcher at Karolinska Institutet, has been elected Incoming Vice Chair for Europe within the International Society for Cell & Gene Therapy (ISCT), a global organization that brings together scientists, clinicians, regulators, and industry partners in the rapidly growing field of advanced therapies.
Her election is a recognition of Lindsay Davies's long-standing engagement and leadership within ISCT. She has been an active member of the organization for over 12 years, holding several key roles, including Secretary for ISCT Europe and, more recently, the first Chair of its European Industry Committee.
"I'm honored by the trust placed in me and look forward to continuing to strengthen the voice of Europe and Sweden in the field of cell and gene therapy," says Lindsay Davies , affiliated to the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. "My focus will be on building upon our strong networks, increasing member engagement, and creating more opportunities for collaboration, particularly between academia, industry, and regulatory bodies."
Pride and support from the Karolinska ATMP Center
At the Karolinska ATMP Center, where Lindsay is involved in several initiatives, the appointment is being celebrated with great enthusiasm.
"Lindsay brings a unique perspective that bridges both research and policy development in the field of advanced therapies," says Knut Steffensen , Director of the Karolinska ATMP Center . "Her appointment to this leadership position is not only a recognition of her individual contribution but also a boost for Swedish and European representation in a globally significant organization."
Europe at the Heart of Future Therapies
ISCT works to translate groundbreaking research into clinically available treatments, with a strong focus on safety, efficacy, and collaboration. Davies sees particularly strong potential in Europe's role moving forward:
"Europe has a solid scientific foundation, but also a complex regulatory landscape. Through coordination and clear communication, we can pave the way for faster implementation of new therapies to the benefit of patients around the world," says Lindsay Davies.
About ISCT
ISCT is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective treatments that improve patients' lives worldwide.
